logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > MDL NO MFCD00017373 Aloe Emodin CAS 481-72-1

MDL NO MFCD00017373 Aloe Emodin CAS 481-72-1

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 481-72-1

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 481-72-1 Aloe Emodin

,

CAS 481-72-1

CAS NO::
481-72-1
Appearance::
Orange Solid
Molecular Formula::
C15H10O5
Molecular Weight::
270.23700
EINECS NO::
207-571-7
MDL NO::
MFCD00017373
CAS NO::
481-72-1
Appearance::
Orange Solid
Molecular Formula::
C15H10O5
Molecular Weight::
270.23700
EINECS NO::
207-571-7
MDL NO::
MFCD00017373
MDL NO MFCD00017373 Aloe Emodin CAS 481-72-1

Product Description:

Product Name: Aloe emodin CAS NO: 481-72-1

 

 

Synonyms:

1,8-Dihydroxy-3-(hydroxymethyl)anthraquinone,3-Hydroxymethylchrysazine,Aloe-emodin;

3-Hydroxymethylchrysazin;

1H-Indazole-3-carboxylic acid,4,5,6,7-tetrahydro-, ethyl ester;

 

 

Chemical & Physical Properties:

Appearance: Orange Solid

Assay :≥99.0%

Density: 1.3280 (rough estimate)

Melting Point: 223-224℃

Storage Condition: 2-8℃

Flash Point: 311.9±26.6 °C

Vapour Pressure: 0.0±1.6 mmHg at 25℃

Index of Refraction: 1.746

Stability: Hygroscopic

 

 

Safety Information:

RTECS: CB6712200

Safety Statements: S26; S36

WGK Germany: 3

Risk Statements: R36/37/38

Hazard Code: Xi

 

 

Aloe emodin is a hydroxyanthraquinone present in Aloe vera leaves, has a specific in vitro and in vivo antitumor activity.IC50 value:Target:in vitro: aloe-emodin treatment led to the dissociation of heat shock protein 90 (HSP90) and ER α and increased ER α ubiquitination. Protein fractionation results suggest that aloe-emodin tended to induce cytosolic ER α degradation. Aloe-emodin, a natural compound found in aloe, inhibited both proliferation and anchorage-independent growth of PC3 cells. Protein content analysis suggested that activation of the downstream substrates of mTORC2, Akt and PKCα, was inhibited by aloe-emodin treatment. Pull-down assay and in vitro kinase assay results indicated that aloe-emodin could bind with mTORC2 in cells and inhibit its kinase activity. Of three anthraquinone derivatives, aloe-emodin, with a lower cytotoxicity showed concentration-dependently reducing virus-induced cytopathic effect and inhibiting replication of influenza A in MDCK cells. Galectin-3 also inhibited influenza A virus replication. Proteomic analysis of treated cells indicated galectin-3 up-regulation as one anti-influenza A virus action by aloe-emodin. Since galectin-3 exhibited cytokine-like regulatory actions via JAK/STAT pathways, aloe-emodin also restored NS1-inhibited STAT1-mediated antiviral responses in transfected cells: e.g., STAT1 phosphorylation of interferon (IFN) stimulation response element (ISRE)-driven promoter, RNA-dependent protein kinase (PKR) and 2'5',-oligoadenylate synthetase (2'5',-OAS) expression. AE downregulated mRNA expression and promoter/gelatinolytic activity of Matrix Metalloproteinase (MMP)-2/9, as well as the RhoB expression at gene and protein level. AE suppressed the nuclear translocation and DNA binding of NF-κB.in vivo: Aloe-emodin also exhibited tumor suppression effects in vivo in an athymic nude mouse model.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.